Hope for Stomach Cancer
Avatar

1L Chemo for Stage 4 Gastroesophageal Cancers: Doublet vs. Triplet

By Hope for Stomach Cancer FEATURING Daniel Catenacci
By Hope for Stomach Cancer FEATURING Daniel Catenacci
164 views
December 19, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Related Content

AUTOPLAY
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
27:12
Moffitt Cancer Center

Year in Review: Upper GI Cancers

Feat. R. Kim, R. Mehta
07:35
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "Gastro-Esophageal Key Studies Including…

Feat. R. Kim, R. Mehta
13:47
Aditya Shreenivas

Neoadjuvant IO in MSI-High GI Cancers: Special Focus on the DREAM GI…

Feat. S. Chakrabarti
09:42
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "MATTERHORN & KEYNOTE-585 C…

Feat. Y. Janjigian, S. Cytryn, S. Klempner
23:27
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "GI Key Studies Including MATTERHORN & K…

Feat. R. Kim, R. Mehta
17:23
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key …

Feat. R. Kim, R. Mehta
18:51
Hope for Stomach Cancer

1L Therapy for Stage 4 Gastroesophageal Cancers: The Role of Biomark…

Feat. D. Catenacci
16:53
Scripps MD Anderson Cancer Center

GC/GEJC/EC Trials - Evolving Landscape and Treatment Guidance

Feat. J. Hecht
10:23
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Randomized Phase 3 GASTFOX Study - 5-fluor…

Feat. A. Zaanan
06:53
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implica…

Feat. Y. Janjigian, S. Cytryn, S. Klempner
04:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Biomarker Analysis of 2 Zolbetuximab Phas…

Feat. K. Shitara
03:31
ecancer

ESMO 2023 Summary: "Highlights From Recent GI Cancer Trials&quo…

Feat. B. Gyawali
08:35
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 3 ATTRACTION-5 Study - Nivo + Chemo…

Feat. M. Terashima
11:02
ASCO GI 2023 Conference Coverage

ASCO GI 2023 3-Year Follow-Up From CheckMate 649: Nivo + Chemo vs. C…

Feat. Y. Y. Janjigian
19:29
Total Health

Case-Based Clinical Updates in GI Cancer: 56 y/o Male With GEJ Adeno…

Feat. R. Mehta, M. Tejani, K. Blue
44:18
Debbie's Dream Foundation

ASCO® 2023 Insights: "What's New in Stomach and Esophageal…

Feat. S. Klempner
24:45
Total Health

2023 Gastro-Esophageal Update

Feat. M. Karimi
29:54
2023 Johns Hopkins Updates in Gastrointestinal Cancers

Gastric Adenocarcinoma: The Peritoneal Conundrum

Feat. F. Johnston